Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
The list of kids with co-morbidities eligible for vaccination would be announced by the government
Support from DFC will help produce one billion vaccine doses by the end of 2022
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Key takeaways of recent quarter & conference call highlights
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
This strategic collaboration will enable continued innovation in cancer care
Subscribe To Our Newsletter & Stay Updated
